ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2360

The Association of Superolateral Hoffa’s Fat Pad Edema and Synovitis with Structural Changes in the Patellofemoral and Tibiofemoral Joints: The Multicenter Osteoarthritis Study

Mohamed Jarraya1, Ali Guermazi2, David T. Felson3, Frank Roemer4, Michael C. Nevitt5, James Torner6, Cora E. Lewis7 and Joshua Stefanik8, 1Mercy Catholic Medical Center, Darby, PA, 2Boston University School of Medicine, Boston, MA, 3Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 4University of Erlangen-Nuremberg, Erlangen, Germany, 5Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 6University of Iowa, UIowa, Iowa City, IA, 7Preventive Medicine, University of Alabama at Birmingham, Birmingham City, AL, 8Physical Therapy, Northeastern University, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Knee, magnetic resonance imaging (MRI) and synovitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Osteoarthritis – Clinical Aspects - Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To determine the relation of superolateral HoffaÕs fat pad (SHFP) edema and Hoffa-synovitis to cartilage damage and bone marrow lesions (BMLs) in the patellofemoral (PF) and tibiofemoral (TF) joints.

Methods: The Multicenter Osteoarthritis (MOST) study is a NIH-funded longitudinal cohort study of older individuals with or at risk for knee OA. We used data from the 60-month study visit where all eligible subjects had knee MRI assessed for other structural features of knee OA. SHFP edema and Hoffa-synovitis (infrapatellar and/or intercondylar) were assessed on sagittal proton density-weighted fat-suppressed MRI images by two musculoskeletal radiologists and dichotomized into presence (>1) and absence (=0). Cartilage damage and BMLs were scored in the PF and TF joints. We used three definitions of structural damage: 1) any cartilage damage (WORMS score of ³2), 2) full-thickness cartilage damage (WORMS score 2.5, 5-6) and 3) any BML (WORMS score of ³1). We further defined the location of PF and TF joint damage in the lateral and medial compartments. Separate logistic regression models were used to determine the relation of SHFP edema to our three definitions of structural damage in the medial and lateral PF and TF joints, adjusting for age, sex and BMI. The same models were used with HoffaÕs synovitis as the exposure instead of SHFP edema.

Results: 1041 knees were included; Mean (sd) age and BMI were 66.8 (7.5) and 29.6 (4.8), respectively; 65% were female. SHFP edema and Hoffa-synovitis was present in 12.7% and 59.3% of knees, respectively. Compared with knees without SHFP edema, knees with SHFP edema showed statistically significant increase in odds of any and full-thickness cartilage damage, and any BML in the lateral PF joint only. Compared with knees without synovitis, knees with Hoffa-synovitis showed statistically significant odds of any and full thickness damage, and BMLs in all 4 compartments (table).

Conclusion: While synovitis is a marker of whole-joint disease, SHFP edema is a surrogate of local lateral PF joint disease only. SHFP edema is likely the result of mechanical impingement and maltracking leading to local structural abnormalities like cartilage and osseous changes. Description: Macintosh HD:Users:mohamedjarraya1:Desktop:Table.jpg


Disclosure: M. Jarraya, None; A. Guermazi, MerckSerono, 5,TissueGene, 5,OrthoTrophix, 5,AstraZeneca, 5,Genzyme Corporation, 5,BICL, 9; D. T. Felson, zimmer knee creations, 5; F. Roemer, BICL, 9; M. C. Nevitt, None; J. Torner, None; C. E. Lewis, None; J. Stefanik, None.

To cite this abstract in AMA style:

Jarraya M, Guermazi A, Felson DT, Roemer F, Nevitt MC, Torner J, Lewis CE, Stefanik J. The Association of Superolateral Hoffa’s Fat Pad Edema and Synovitis with Structural Changes in the Patellofemoral and Tibiofemoral Joints: The Multicenter Osteoarthritis Study [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/the-association-of-superolateral-hoffas-fat-pad-edema-and-synovitis-with-structural-changes-in-the-patellofemoral-and-tibiofemoral-joints-the-multicenter-osteoarthritis-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-of-superolateral-hoffas-fat-pad-edema-and-synovitis-with-structural-changes-in-the-patellofemoral-and-tibiofemoral-joints-the-multicenter-osteoarthritis-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology